Quigley's Cold-Eeze

Line extensions to include sugar-free Cold-Eeze and a "one- day dosage" package containing six lozenges. The company plans to market sugar-free Cold-Eeze in a 30-minute television infomercial this fall appealing to diabetics and other consumers concerned with sugar intake. Quigley will begin to market its "one-day dosage" package during the third quarter...

More from Archive

More from Pink Sheet

What UK’s Clinical Trials Overhaul Means For Orphan Drug Developers

 

The UK government has acknowledged that sponsors of clinical trials for rare diseases face challenges around patient recruitment and trial design, which will be addressed in its clinical trials reform, a lawyer says.

Crisis Or Opportunity? US MFN Policy Could Test Japan’s Appetite For Reforms

 
• By 

While the adoption of most favored nation drug pricing in the US stands to affect Japanese biopharma firms now heavily reliant on this market, it might also present an opportunity for pricing and policy reforms at home.

ACIP Upheaval Leaves Merck & Co. In A Lurch

 

Merck’s newly approved Enflonsia for RSV is one of the products expected to be recommended for use by the CDC Advisory Committee on Immunization Practices later this month.